Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on October 31, 2007
J Am Soc Nephrol 18: 3192-3198, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2007030349

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007030349v1
18/12/3192    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hurst, F. P.
Right arrow Articles by Abbott, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hurst, F. P.
Right arrow Articles by Abbott, K. C.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH

Association of Oral Sodium Phosphate Purgative Use with Acute Kidney Injury

Frank P. Hurst*, Erin M. Bohen*, Eric M. Osgard{dagger}, David K. Oliver*, Nealanjon P. Das*, Sam W. Gao* and Kevin C. Abbott*

* Nephrology Service and {dagger} Gastroenterology Service, Walter Reed Army Medical Center, Washington, DC, and Uniformed Services University of the Health Sciences, Bethesda, Maryland

Correspondence: Dr. Frank P. Hurst, US Army, Walter Reed Army Medical Center, Washington, DC 20307. Phone: 202-782-6462; Fax: 202-782-0185; E-mail: frank.hurst{at}us.army.mil

Received for publication March 22, 2007. Accepted for publication August 10, 2007.

Oral sodium phosphate (OSP) is a commonly used purgative before colonoscopy. There have been numerous reports of acute phosphate nephropathy attributed to the use of OSP. This study evaluated the association between the use of OSP and acute kidney injury (AKI) in an observational, retrospective, cohort study. Of 9799 patients who underwent colonoscopy and had serum creatinine values recorded within 365 days before and after the procedure, AKI, defined as ≥50% increase in baseline serum creatinine, was identified in 114 (1.16%). After adjustment for significant covariates in a multiple logistic regression model, the use of OSP was associated with increased risk for AKI (odds ratio 2.35; 95% confidence interval 1.51 to 3.66; P < 0.001) with an adjusted number need to harm of 81. Age was also independently associated with AKI in this cohort; therefore, until larger, prospective studies define the population at risk for acute phosphate nephropathy, the use of polyethylene glycol-based purgatives should be considered for older patients and possibly for those with comorbid medical conditions.


Related Article

Towards the Incidence of Acute Phosphate Nephropathy
Glen S. Markowitz, Jai Radhakrishnan, and Vivette D. D'Agati
J. Am. Soc. Nephrol. 2007 18: 3020-3022. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
G. Lichtenstein
Bowel preparations for colonoscopy: A review
Am. J. Health Syst. Pharm., January 1, 2009; 66(1): 27 - 37.
[Abstract] [Full Text] [PDF]


Home page
NDT PlusHome page
S. Burtey, L. Daniel, H. Vacher-Coponat, B. Dussol, and Y. Berland
Renal failure associated with colonoscopy--what is the link?
NDT Plus, December 1, 2008; 1(6): 450 - 451.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
K. C. Abbott, E. M. Bohen, and F. P. Hurst
Oral Sodium Phosphate Drug Products and Renal Function
Arch Intern Med, November 10, 2008; 168(20): 2285 - 2285.
[Full Text] [PDF]


Home page
CJASNHome page
E. C. Heher, S. O. Thier, H. Rennke, and B. D. Humphreys
Adverse Renal and Metabolic Effects Associated with Oral Sodium Phosphate Bowel Preparation
Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1494 - 1503.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
A. Connor, L. Sykes, I. S D Roberts, and C. E Weston
Acute phosphate nephropathy after sodium phosphate preparations
BMJ, July 17, 2008; 337(jul17_1): a182 - a182.
[Full Text]


Home page
NDT PlusHome page
S. M. Brunelli, J. D. Lewis, K. E. Lynch, M. M. Joffe, M. Gupta, S. M. Latif, M. G. Weiner, and H. I. Feldman
Investigation of the association between oral sodium phosphate use and kidney injury
NDT Plus, June 1, 2008; 1(3): 190 - 192.
[Full Text] [PDF]


Home page
CJASNHome page
N. Gibney, E. Hoste, E. A. Burdmann, T. Bunchman, V. Kher, R. Viswanathan, R. L. Mehta, and C. Ronco
Timing of Initiation and Discontinuation of Renal Replacement Therapy in AKI: Unanswered Key Questions
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 876 - 880.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. S. Markowitz, J. Radhakrishnan, and V. D. D'Agati
Towards the Incidence of Acute Phosphate Nephropathy
J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3020 - 3022.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP